Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference
Journal Paper/Review - Apr 8, 2022
Kolberg-Liedtke Cornelia, Luftner Diana, Brucker Sara Y, Budach Wilfried, Denkert Carsten, Fasching Peter A, Haidinger Renate, Harbeck Nadia, Huober Jens, Jackisch Christian, Janni Wolfgang, Krug David, Kühn Thorsten, Loibl Sibylle, Müller Volkmar, Schneeweiss Andreas, Thomssen Christoph, Untch Michael, Thill Marc
The general topic of this year's 17th St. Gallen (SG) International Consensus Conference on the treatment of patients with early breast cancer (SG-BCC) was "Customizing local and systemic therapies for women with early breast cancer." This topic considers that each treatment decision must also consider the cancer-specific situation of the individual patient. This year, the votes of the SG-BCC were again discussed taking into account the multidisciplinary German S3 Guidelines and the recommendations of the Breast Cancer Working Group of the AGO (Arbeitsgemeinschaft Gynäkologische Onkologie; AGO Mamma). As the international panel of the SG-BCC consists of experts from different countries, the votes do represent an international cross-section of opinions. Therefore, it is useful to discuss the voting results with respect to the German evidence-based treatment guidelines. This publication focuses mainly on systemic treatment.